Business · 08/11/2007Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting to Discuss Proposed Rule on Ozone-Depleting Substances and Epinephrine
Summary
The FDA is hosting a public meeting to gather comments on a proposed rule that would remove the essential-use designation for epinephrine-containing oral pressurized metered-dose inhalers, following the publication of the rule in the Federal Register on September 20, 2007.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →